The company has revised its revenue projection for the fiscal year 2025, anticipating a growth rate of 15% to 17% compared to the previous forecast of 12.5% to 14.5%. This significant increase underscores the company's confidence in its operational strategies and market conditions.
According to the latest estimates, this growth will reflect in both reported and organic net sales. The company expects reported net sales to rise by 15% to 17%, while organic sales, which exclude foreign currency impacts and sales from smaller acquisitions and divestitures, are predicted to grow by 12% to 14%.
In terms of earnings, the company projects a GAAP earnings per share (EPS) in the range of $1.86 to $1.93. When adjusted for specific charges, the EPS is expected to be between $2.87 and $2.94. This adjusted EPS outlook slightly surpasses the consensus estimate of $2.86, showcasing a positive financial performance expectation.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 30 analysts, the average target price for Boston Scientific Corp (BSX, Financial) is $116.34 with a high estimate of $130.00 and a low estimate of $84.11. The average target implies an upside of 22.40% from the current price of $95.05. More detailed estimate data can be found on the Boston Scientific Corp (BSX) Forecast page.
Based on the consensus recommendation from 34 brokerage firms, Boston Scientific Corp's (BSX, Financial) average brokerage recommendation is currently 1.8, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Boston Scientific Corp (BSX, Financial) in one year is $76.94, suggesting a downside of 19.05% from the current price of $95.05. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Boston Scientific Corp (BSX) Summary page.
